| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |